Abstract
Healthcare-associated infections (HAIs) are a leading cause of mortality and morbidity globally. Intensive care unit (ICU)-acquired infections represent the majority of HAIs and are most often associated with the use of invasive medical devices. These infections highly correlate with bacterial colonization and biofilm formation on the devices and can be complicated by other device-associated complications. In this chapter, advances in antimicrobial modifications on implantable medical devices, especially on typical critical care implants, are reviewed. The first part of the chapter introduces biofilm formation and its clinical linkage to HAIs. The second part reviews three infections classified by devices, i.e., catheter-related bloodstream infection (CRBSI), ventilator-associated pneumonia (VAP), and catheter-associated urinary tract infection (CAUTI), summarizing their causes, etiologic agents, and infection–complication relationship. The third part of the chapter investigates three typical critical care implants, i.e., vascular catheters, endotracheal tubes, and urinary catheters, focusing on substrate polymers and functional coatings to reduce device-associated complications especially those have been clinically evaluated. The last part overviews technologies have yet been clinically approved on medical implants but shown promising results to reduce bacterial colonization or biofilm formation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/ClassifyYourDevice/ucm051512.htm. Is The Product A Medical Device? 2014
J.D. Bryers, Medical biofilms. Biotechnol. Bioeng. 100(1), 1–18 (2008)
J.W. Costerton et al., Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 41, 435–464 (1987)
R.M. Donlan, Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8(9), 881–890 (2002)
K. Sauer et al., Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 184(4), 1140–1154 (2002)
D.G. Davies et al., The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280(5361), 295–298 (1998)
M.R. Parsek, E.P. Greenberg, Sociomicrobiology: the connections between quorum sensing and biofilms. Trends Microbiol. 13(1), 27–33 (2005)
T.J. Marrie, J.W. Costerton, Morphology of bacterial attachment to cardiac pacemaker leads and power packs. J. Clin. Microbiol. 19(6), 911–914 (1984)
M. Jacques, T.J. Marrie, J.W. Costerton, Review: microbial colonization of prosthetic devices. Microb. Ecol. 13(3), 173–191 (1987)
T.R. Franson et al., Scanning electron microscopy of bacteria adherent to intravascular catheters. J. Clin. Microbiol. 20(3), 500–505 (1984)
T.J. Marrie, J.Y. Sung, J.W. Costerton, Bacterial biofilm formation on nasogastric tubes. J. Gastroenterol. Hepatol. 5(5), 503–506 (1990)
R.M. Donlan, J.W. Costerton, Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15(2), 167–193 (2002)
L. Hall-Stoodley, P. Stoodley, Evolving concepts in biofilm infections. Cell. Microbiol. 11(7), 1034–1043 (2009)
J.P. Burke, Infection control — a problem for patient safety. N. Engl. J. Med. 348(7), 651–656 (2003)
M.C. Barsanti, K.F. Woeltje, Infection prevention in the intensive care unit. Infect. Dis. Clin. 23(3), 703–725 (2009)
R. Gahlot et al., Catheter-related bloodstream infections. Int. J. Crit. Illn. Inj. Sci. 4(2), 162–167 (2014)
H. Shah et al., Intravascular catheter-related bloodstream infection. Neurohospitalist 3(3), 144–151 (2013)
D. Frasca, C. Dahyot-Fizelier, O. Mimoz, Prevention of central venous catheter-related infection in the intensive care unit. Crit. Care 14(2), 212–212 (2010)
L.A. Mermel, Prevention of intravascular catheter-related infections. Ann. Intern. Med. 132(5), 391–402 (2000)
S.I. Blot et al., Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin. Infect. Dis. 41(11), 1591–1598 (2005)
J. Liñares, Diagnosis of catheter-related bloodstream infection: conservative techniques. Clin. Infect. Dis. 44(6), 827–829 (2007)
N.P. O’Grady et al., Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am 52(9), 1087–1099 (2011)
L.A. Mermel, What is the predominant source of intravascular catheter infections? Clin. Infect. Dis. 52(2), 211–212 (2011)
I. Raad et al., Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J. Infect. Dis. 168(2), 400–407 (1993)
S.F. Fitzgerald et al., A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done. J. Hosp. Infect. 79(3), 218–221 (2011)
I. Raad et al., Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur. J. Clin. Microbiol. Infect. Dis. 26(8), 549–556 (2007)
A. Sitges-Serra et al., Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 8(6), 668–672 (1984)
A.R. Marra et al., Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J. Clin. Gastroenterol. 41(1), 19–28 (2007)
L. Lorente et al., Microorganisms responsible for intravascular catheter-related bloodstream infection according to the catheter site. Crit. Care Med. 35(10), 2424–2427 (2007)
K. Cheong et al., High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours. Intern. Med. J. 34(5), 234–238 (2004)
B. Ong et al., Peripherally inserted central catheters and upper extremity deep vein thrombosis. Australas. Radiol. 50(5), 451–454 (2006)
B.L. Lobo et al., Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters. J. Hosp. Med. 4(7), 417–422 (2009)
P. Sriskandarajah et al., Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients. Thromb. J. 13(21), 015–0052 (2015)
J.D. Paauw et al., The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants. JPEN J. Parenter. Enteral Nutr. 32(4), 443–447 (2008)
T. Marnejon et al., Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters. J. Vasc. Access 13(2), 231–238 (2012)
R.S. Boersma et al., Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann. Oncol. 19(3), 433–442 (2008)
M. Herrmann et al., Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J. Infect. Dis. 158(4), 693–701 (1988)
J.R. Mehall et al., Fibrin sheath enhances central venous catheter infection. Crit. Care Med. 30(4), 908–912 (2002)
I.I. Raad et al., The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271(13), 1014–1016 (1994)
J.F. Timsit et al., Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 114(1), 207–213 (1998)
C.J. van Rooden et al., Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J. Clin. Oncol. 23(12), 2655–2660 (2005)
S.M. Koenig, J.D. Truwit, Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin. Microbiol. Rev. 19(4), 637–657 (2006)
I.A. Pneumatikos, C.K. Dragoumanis, D.E. Bouros, Ventilator-associated pneumonia or endotracheal tube-associated pneumonia? An approach to the pathogenesis and preventive strategies emphasizing the importance of endotracheal tube. Anesthesiology 110(3), 673–680 (2009)
J. Chastre, J. Fagon, Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 165(7), 867–903 (2002)
M.D.M.C. Villafane et al., Gradual reduction of endotracheal tube diameter during mechanical ventilation via different humidification devices. Anesthesiology 85(6), 1341–1349 (1996)
M.C. Boque et al., Endotracheal tube intraluminal diameter narrowing after mechanical ventilation: use of acoustic reflectometry. Intensive Care Med. 30(12), 2204–2209 (2004)
C. Shah, M.H. Kollef, Endotracheal tube intraluminal volume loss among mechanically ventilated patients. Crit. Care Med. 32(1), 120–125 (2004)
P.-E. Danin et al., Description and microbiology of endotracheal tube biofilm in mechanically ventilated subjects. Respir. Care 60(1), 21–29 (2015)
I.L. Cohen et al., Endotracheal tube occlusion associated with the use of heat and moisture exchangers in the intensive care unit. Crit. Care Med. 16(3), 277–279 (1988)
R. Donlan, Biofilms and device-associated infections. Emerg. Infect. Dis. 7(2), 277–281 (2001)
S.M. Jacobsen et al., Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 21(1), 26–59 (2008)
G.A. O’May et al., Complicated urinary tract infections due to catheters. Role Biofilms Dev. Relat. Infect. 3, 123–165 (2009)
D. Stickler et al., Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm? Urol. Res. 31(5), 306–311 (2003)
J.W. Warren et al., A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J. Infect. Dis. 146(6), 719–723 (1982)
D.J. Stickler, Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done. J. Intern. Med. 276(2), 120–129 (2014)
A.J. Cox, D.W. Hukins, Morphology of mineral deposits on encrusted urinary catheters investigated by scanning electron microscopy. J. Urol. 142(5), 1347–1350 (1989)
D. Stickler et al., Proteus mirabilis biofilms and the encrustation of urethral catheters. Urol. Res. 21(6), 407–411 (1993)
H.L. Mobley, J.W. Warren, Urease-positive bacteriuria and obstruction of long-term urinary catheters. J. Clin. Microbiol. 25(11), 2216–2217 (1987)
B.D. Jones, H.L. Mobley, Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection. Infect. Immun. 55(9), 2198–2203 (1987)
N.S. Morris, D.J. Stickler, R.J. McLean, The development of bacterial biofilms on indwelling urethral catheters. World J. Urol. 17(6), 345–350 (1999)
M. Santin et al., Effect of the urine conditioning film on ureteral stent encrustation and characterization of its protein composition. Biomaterials 20(13), 1245–1251 (1999)
B.K. Canales et al., Presence of five conditioning film proteins are highly associated with early stent encrustation. J. Endourol. 23(9), 1437–1442 (2009)
R.J. Sherertz et al., Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo. J. Biomed. Mater. Res. 29(5), 635–645 (1995)
A.B. Cohen et al., Silicone and polyurethane tunneled infusion catheters: a comparison of durability and breakage rates. J. Vasc. Interv. Radiol. 22(5), 638–641 (2011)
S. Galloway, A. Bodenham, Long-term central venous access. Br. J. Anaesth. 92(5), 722–734 (2004)
M. Wildgruber et al., Polyurethane versus silicone catheters for central venous port devices implanted at the forearm. Eur. J. Cancer 59, 113–124 (2016)
A.J. Coury et al., Factors and interactions affecting the performance of polyurethane elastomers in medical devices. J. Biomater. Appl. 3(2), 130–179 (1988)
M.G. Tal, N. Ni, Selecting optimal hemodialysis catheters: material, design, advanced features, and preferences. Tech. Vascular. Interv. Radiol. 11(3), 186–191 (2008)
M.-G. Knuttinen et al., A review of evolving dialysis catheter technologies. Semin. Interv. Radiol. 26(2), 106–114 (2009)
A. Dwyer, Surface-treated catheters – a review. Semin. Dial. 21(6), 542–546 (2008)
N.M. Lai et al., Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst. Rev. 16(3), CD007878 (2016)
K. Blom, M. Werthen, A laboratory study of the synergistic effect of chlorhexidine and silver. Am. J. Infect. Control 43(6), S22 (2015)
D.L. Veenstra et al., Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281(3), 261–267 (1999)
A. Bach, Clinical studies on the use of antibiotic- and antiseptic-bonded catheters to prevent catheter-related infection. Zentralblatt für Bakteriologie 283(2), 208–214 (1995)
D.L. Miller, N.P. O’Grady, Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology for venous catheter placement and maintenance. J. Vasc. Interv. Radiol. 23(8), 997–1007 (2012)
D.G. Maki et al., Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann. Intern. Med. 127(4), 257–266 (1997)
Q.L. Feng et al., A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J. Biomed. Mater. Res. 52(4), 662–668 (2000)
S.K. Kakkos et al., Effectiveness of a new tunneled catheter in preventing catheter malfunction: a comparative study. J. Vascular Interv. Radiol. 19(7), 1018–1026 (2008)
C. Ye et al., A retrospective study of palindrome symmetrical-tip catheters for chronic hemodialysis access in China. Ren. Fail. 37(6), 941–946 (2015)
J.-P. Guggenbichler et al., A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 27(1), S16–S23 (1999)
L. Corral et al., A prospective, randomized study in critically ill patients using the Oligon Vantex catheter. J. Hosp. Infect. 55(3), 212–219 (2003)
P. Kalfon et al., Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit. Care Med. 35(4), 1032–1039 (2007)
H. Wang et al., Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. J. Hosp. Infect. 76(1), 1–11 (2010)
R. Bambauer et al., Long-term catheters for apheresis and dialysis with surface treatment with infection resistance and low thrombogenicity. Ther. Apher. Dial. 7(2), 225–231 (2003)
R. Bambauer et al., Surface-treated versus untreated large-bore catheters as vascular access in hemodialysis and apheresis treatments. Int. J. Nephrol. 2012, 956136 (2012)
S.E. Tebbs, T.S.J. Elliott, A novel antimicrobial central venous catheter impregnated with benzalkonium chloride. J. Antimicrob. Chemother. 31(2), 261–271 (1993)
H.A. Moss et al., A central venous catheter coated with benzalkonium chloride for the prevention of catheter-related microbial colonization. Eur. J. Anaesthesiol. 17(11), 680–687 (2000)
K. Jaeger et al., Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients. Chemotherapy 47(1), 50–55 (2001)
I. Chopra, M. Roberts, Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65(2), 232–260 (2001)
G.N. Forrest, K. Tamura, Rifampin combination therapy for nonmycobacterial infections. Clin. Microbiol. Rev. 23(1), 14–34 (2010)
J. Segreti, L.C. Gvazdinskas, G.M. Trenholme, In vitro activity of minocycline and rifampin against staphylococci. Diagn. Microbiol. Infect. Dis. 12(3), 253–255 (1989)
I. Raad et al., Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann. Intern. Med. 127(4), 267–274 (1997)
H. Hanna et al., Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J. Clin. Oncol. 22(15), 3163–3171 (2004)
M.E. Falagas et al., Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J. Antimicrob. Chemother. 59(3), 359–369 (2007)
S. Bonne et al., Effectiveness of minocycline and rifampin vs chlorhexidine and silver sulfadiazine-impregnated central venous catheters in preventing central line-associated bloodstream infection in a high-volume academic intensive care unit: a before and after trial. J. Am. Coll. Surg. 221(3), 739–747 (2015)
R.W. Allan et al., Embolization of hydrophilic catheter coating to the lungs. Rep. Case. Mimick. Granulomatous Vasculitis 132(5), 794–797 (2009)
I. Raad et al., Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob. Agents Chemother. 56(2), 935–941 (2012)
A. Barasch, A.V. Griffin, Miconazole revisited: new evidence of antifungal efficacy from laboratory and clinical trials. Future Microbiol 3(3), 265–269 (2008)
N. Yücel et al., Reduced colonization and infection with miconazole–rifampicin modified central venous catheters: a randomized controlled clinical trial. J. Antimicrob. Chemother. 54(6), 1109–1115 (2004)
J.M. Schierholz et al., Antimicrobial central venous catheters in oncology: efficacy of a rifampicin–miconazole-releasing catheter. Anticancer Res. 30(4), 1353–1358 (2010)
L. Lorente et al., The use of rifampicin-miconazole—impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Clin. Infect. Dis. 47(9), 1171–1175 (2008)
G.D. Kamal et al., Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA 265(18), 2364–2368 (1991)
J.H. Gieringer et al., Effect of 5-fluorouracil, mitoxantrone, methotrexate, and vincristine on the antibacterial activity of ceftriaxone, ceftazidime, cefotiam, piperacillin, and netilmicin. Chemotherapy 32(5), 418–424 (1986)
C. Kesavan, A.G. Joyee, 5-fluorouracil altered morphology and inhibited growth of Candida albicans. J. Clin. Microbiol. 43(12), 6215–6216 (2005)
R. Avelar, A. Jonker, 5 – Catheter-based drug–device combination products: the anti-infective 5-fluorouracil-coated central venous catheter A2 – Lewis, Andrew, in Drug-Device Combination Products, (Woodhead Publishing, Oxford, 2010), pp. 93–116
J.M. Walz et al., Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization. Crit. Care Med. 38(11), 2095–2102 (2010)
S.K. Schmitt et al., Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. J. Clin. Microbiol. 34(3), 508–511 (1996)
J.I. Greenfeld et al., Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Crit. Care Med. 23(5), 894–900 (1995)
L.A. Sampath et al., Infection resistance of surface modified catheters with either short-lived or prolonged activity. J. Hosp. Infect. 30(3), 201–210 (1995)
M.N. Carrasco et al., Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intensive Care Med. 30(4), 633–638 (2004)
M.E. Rupp et al., Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter–related infections: A randomized, controlled trial. Ann. Intern. Med. 143(8), 570–580 (2005)
C. Brun-Buisson et al., Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med. 30(5), 837–843 (2004)
K. Yorganci et al., Activity of antibacterial impregnated central venous catheters against Klebsiella pneumoniae. Intensive Care Med. 28(4), 438–442 (2002)
S. Murugesan, J. Xie, R.J. Linhardt, Immobilization of heparin: approaches and applications. Curr. Top. Med. Chem. 8(2), 80–100 (2008)
O. Larm, R. Larsson, P. Olsson, A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater. Med. Devices Artif. Organs 11(2–3), 161–173 (1983)
U.R. Nilsson et al., Modification of the complement binding properties of polystyrene: effects of end-point heparin attachment. Scand. J. Immunol. 37(3), 349–354 (1993)
C. Arnander et al., Long-term stability in vivo of a thromboresistant heparinized surface. Biomaterials 8(6), 496–499 (1987)
P.L. Foley, C.H. Barthel, H.R. Brausa, Effect of covalently bound heparin coating on patency and biocompatibility of long-term indwelling catheters in the rat jugular vein. Comp. Med. 52(3), 243–248 (2002)
P. Appelgren et al., Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: Results from a prospective, randomized trial. Crit. Care Med. 24(9), 1482–1489 (1996)
P. Appelgren et al., Does surface heparinisation reduce bacterial colonisation of central venous catheters? Lancet 345(8942), 130 (1995)
G. Jain et al., Does heparin coating improve patency or reduce infection of tunneled dialysis catheters? Clin. J. Am. Soc. Nephrol. CJASN 4(11), 1787–1790 (2009)
H.T. Tevaearai et al., Trillium coating of cardiopulmonary bypass circuits improves biocompatibility. Int. J. Artif. Organs 22(9), 629–634 (1999)
Y.W. Tang et al., Synthesis of surface-modifying macromolecules for use in segmented polyurethanes. J. Appl. Polym. Sci. 62(8), 1133–1145 (1996)
C.B. McCloskey, C.M. Yip, J.P. Santerre, Effect of fluorinated surface-modifying macromolecules on the molecular surface structure of a polyether poly(urethane urea). Macromolecules 35(3), 924–933 (2002)
C.F. Haas et al., Endotracheal tubes: old and new. Respir. Care 59(6), 933–952 (2014)
W.J. Morton et al., Investigation of phthalate release from tracheal tubes. Anaesthesia 68(4), 377–381 (2013)
G. Latini et al., Di-(2-ethylhexyl)phthalate leakage and color changes in endotracheal tubes after application in high-risk newborns. Neonatology 95(4), 317–323 (2009)
R. Ito et al., Determination of tris(2-ethylhexyl)trimellitate released from PVC tube by LC-MS/MS. Int. J. Pharm. 360(1–2), 91–95 (2008)
F. Chiellini et al., Perspectives on alternatives to phthalate plasticized poly(vinyl chloride) in medical devices applications. Prog. Polym. Sci. 38(7), 1067–1088 (2013)
M.E. Olson, B.G. Harmon, M.H. Kollef, Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest 121(3), 863–870 (2002)
J. Rello et al., Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study*. Crit. Care Med. 34(11), 2766–2772 (2006)
M.H. Kollef et al., Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: The nascent randomized trial. JAMA 300(7), 805–813 (2008)
M.D.L. Berra et al., Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube. Anesthesiology 100(6), 1446–1456 (2004)
L. Berra et al., Antimicrobial-coated endotracheal tubes: an experimental study. Intensive Care Med. 34(6), 1020–1029 (2008)
R.M. Epand, R.F. Epand, P.B. Savage, Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents. Drug News Perspect. 21(6), 307–311 (2008)
M. Moscoso et al., In vitro bactericidal and bacteriolytic activity of ceragenin CSA-13 against planktonic cultures and biofilms of Streptococcus pneumoniae and other pathogenic streptococci. PLoS One 9(7), e101037 (2014)
D.L. Williams et al., In vivo efficacy of a silicone–cationic steroid antimicrobial coating to prevent implant-related infection. Biomaterials 33(33), 8641–8656 (2012)
H. Hedelin et al., Relationship between urease-producing bacteria, urinary pH and encrustation on indwelling urinary catheters. Br. J. Urol. 67(5), 527–531 (1991)
I. Pomfret, Urinary catheters: selection, management and prevention of infection. Br. J. Community Nurs. 5(1), 6–8 (2000)
G.S. Robertson et al., Effect of catheter material on the incidence of urethral strictures. Br. J. Urol. 68(6), 612–617 (1991)
T.M. Hamill et al., Strategies for the development of the urinary catheter. Expert Rev. Med. Devices 4(2), 215–225 (2007)
M. Talja, A. Korpela, K. Jarvi, Comparison of urethral reaction to full silicone, hydrogen-coated and siliconised latex catheters. Br. J. Urol. 66(6), 652–657 (1990)
H. Kumon et al., Catheter-associated urinary tract infections: impact of catheter materials on their management. Int. J. Antimicrobial Agents 17(4), 311–316 (2001)
T.A. Gaonkar, L.A. Sampath, S.M. Modak, Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model. Infect. Control Hosp. Epidemiol. 24(7), 506–513 (2003)
D.K. Riley et al., A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am. J. Med. 98(4), 349–356 (1995)
J.R. Johnson, B. Johnston, M.A. Kuskowski, In vitro comparison of nitrofurazone- and silver alloy-coated foley catheters for contact-dependent and diffusible inhibition of urinary tract infection-associated microorganisms. Antimicrob. Agents Chemother. 56(9), 4969–4972 (2012)
S.J. Lee et al., A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. Int. J. Antimicrob. Agents 24(1), S65–S69 (2004)
J. Stensballe et al., Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients – a randomized trial. Ann. Intern. Med. 147(5), 285–293 (2007)
T.B. Lam et al., Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database Syst. Rev. 23(9), CD004013 (2014)
R.O. Darouiche et al., Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 54(6), 976–981 (1999)
L. Cormio et al., Bacterial adhesion to urethral catheters: role of coating materials and immersion in antibiotic solution. Eur. Urol. 40(3), 354–358 (2001)
M.M. Tunney, S.P. Gorman, Evaluation of a poly(vinyl pyrollidone)-coated biomaterial for urological use. Biomaterials 23(23), 4601–4608 (2002)
E. Bull et al., Single-blind, randomised, parallel group study of the Bard Biocath catheter and a silicone elastomer coated catheter. Br. J. Urol. 68(4), 394–399 (1991)
J.A. Roberts, M. Bernice Kaack, E.N. Fussell, Adherence to urethral catheters by bacteria causing nosocomial infections. Urology 41(4), 338–342 (1993)
J.H. Park et al., Assessment of PEO/PTMO multiblock copolymer/segmented polyurethane blends as coating materials for urinary catheters: in vitro bacterial adhesion and encrustation behavior. Biomaterials 23(19), 3991–4000 (2002)
L. Brisset et al., In vivo and in vitro analysis of the ability of urinary catheter to microbial colonization. Pathol. Biol. 44(5), 397–404 (1996)
N.S. Morris, D.J. Stickler, Encrustation of indwelling urethral catheters by “Proteus mirabilis” biofilms growing in human urine. J. Hosp. Infect. 39(3), 227–234 (1998)
S.A.V. Holmes, C. Cheng, H.N. Whitfield, The development of synthetic polymers that resist encrustation on exposure to urine. Br. J. Urol. 69(6), 651–655 (1992)
N. Venkatesan et al., Polymers as ureteral stents. J. Endourol. 24(2), 191–198 (2010)
H. Liedberg, T. Lundeberg, P. Ekman, Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. An experimental and clinical study. Eur. Urol. 17(3), 236–240 (1990)
P. Jahn, K. Beutner, G. Langer, Types of indwelling urinary catheters for long-term bladder drainage in adults. Cochrane Database Syst. Rev. 17(10), CD004997 (2012)
S.K. Wassil, C.M. Crill, S.J. Phelps, Antimicrobial impregnated catheters in the prevention of catheter-related bloodstream infection in hospitalized patients. J. Pediatr. Pharmacol. Ther. JPPT 12(2), 77–90 (2007)
M. Zilberman, J.J. Elsner, Antibiotic-eluting medical devices for various applications. J. Control. Release 130(3), 202–215 (2008)
M. Zilberman et al., Drug-eluting medical implants, in Drug Delivery, ed. by M. Schäfer-Korting, (Springer, Berlin/Heidelberg, 2010), pp. 299–341
M. Ma et al., Local delivery of antimicrobial peptides using self-organized TiO2 nanotube arrays for peri-implant infections. J. Biomed. Mater. Res. A 100A(2), 278–285 (2012)
M. Lucke et al., Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32(5), 521–531 (2003)
T. Kälicke et al., Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: An in vitro and in vivo study. J. Orthop. Res. 24(8), 1622–1640 (2006)
R.G. Richards et al., Infection in fracture fixation. From basic research, to diagnosis, to evidence-based treatment Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 37(2), S105–S112 (2006)
T. Fuchs et al., The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Arch. Orthop. Trauma Surg. 131(10), 1419–1425 (2011)
A. Shrivastav, H.-Y. Kim, Y.-R. Kim, Advances in the applications of polyhydroxyalkanoate nanoparticles for novel drug delivery system. Biomed. Res. Int. 2013, 12 (2013)
İ. Gürsel et al., In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials 22(1), 73–80 (2000)
F. Turesin, I. Gursel, V. Hasirci, Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release. J. Biomater. Sci. Polym. Ed. 12(2), 195–207 (2001)
S. Rossi, A.O. Azghani, A. Omri, Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system. J. Antimicrob. Chemother. 54(6), 1013–1018 (2004)
R.N. Dave, H.M. Joshi, V.P. Venugopalan, Novel biocatalytic polymer-based antimicrobial coatings as potential ureteral biomaterial: preparation and in vitro performance evaluation. Antimicrob. Agents Chemother. 55(2), 845–853 (2011)
M. Tanihara et al., A novel microbial infection-responsive drug release system. J. Pharm. Sci. 88(5), 510–514 (1999)
N.J. Irwin et al., Infection-responsive drug delivery from urinary biomaterials controlled by a novel kinetic and thermodynamic approach. Pharm. Res. 30(3), 857–865 (2013)
C.P. McCoy et al., An infection-responsive approach to reduce bacterial adhesion in urinary biomaterials. Mol. Pharm. 13(8), 2817–2822 (2016)
V.V. Komnatnyy et al., Bacteria-triggered release of antimicrobial agents. Angew. Chem. Int. Ed. 53(2), 439–441 (2014)
J.C. Tiller et al., Designing surfaces that kill bacteria on contact. Proc. Natl. Acad. Sci. U. S. A. 98(11), 5981–5985 (2001)
S.B. Lee et al., Permanent, nonleaching antibacterial surfaces. 1. synthesis by atom transfer radical polymerization. Biomacromolecules 5(3), 877–882 (2004)
N.M. Milovic et al., Immobilized N-alkylated polyethylenimine avidly kills bacteria by rupturing cell membranes with no resistance developed. Biotechnol. Bioeng. 90(6), 715–722 (2005)
A. Popa et al., Study of quaternary ‘onium’ salts grafted on polymers: antibacterial activity of quaternary phosphonium salts grafted on ‘gel-type’ styrene–divinylbenzene copolymers. React. Funct. Polym. 55(2), 151–158 (2003)
D.D. Iarikov et al., Antimicrobial surfaces using covalently bound polyallylamine. Biomacromolecules 15(1), 169–176 (2014)
R. Wang et al., Inhibition of Escherichia coli and proteus mirabilis adhesion and biofilm formation on medical grade silicone surface. Biotechnol. Bioeng. 109(2), 336–345 (2012)
A. Asadinezhad et al., An in vitro bacterial adhesion assessment of surface-modified medical-grade PVC. Colloids Surf. B: Biointerfaces 77(2), 246–256 (2010)
L. Chen et al., Electrospun cellulose acetate fibers containing chlorhexidine as a bactericide. Polymer 49(5), 1266–1275 (2008)
Y. Guan et al., Antimicrobial-modified sulfite pulps prepared by in situ copolymerization. Carbohydr. Polym. 69(4), 688–696 (2007)
F. Costa et al., Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces. Acta Biomater. 7(4), 1431–1440 (2011)
M. Zasloff, Antimicrobial peptides of multicellular organisms. Nature 415(6870), 389–395 (2002)
B. Gottenbos et al., In vitro and in vivo antimicrobial activity of covalently coupled quaternary ammonium silane coatings on silicone rubber. Biomaterials 23(6), 1417–1423 (2002)
N. Aumsuwan, S. Heinhorst, M.W. Urban, The effectiveness of antibiotic activity of penicillin attached to expanded poly(tetrafluoroethylene) (ePTFE) surfaces: a quantitative assessment. Biomacromolecules 8(11), 3525–3530 (2007)
N. Aumsuwan et al., Attachment of ampicillin to expanded poly(tetrafluoroethylene): surface reactions leading to inhibition of microbial growth. Biomacromolecules 9(7), 1712–1718 (2008)
N. Aumsuwan, M.S. McConnell, M.W. Urban, Tunable antimicrobial polypropylene surfaces: simultaneous attachment of penicillin (Gram +) and gentamicin (Gram −). Biomacromolecules 10(3), 623–629 (2009)
J.-Y. Wach, S. Bonazzi, K. Gademann, Antimicrobial surfaces through natural product hybrids. Angew. Chem. Int. Ed. 47(37), 7123–7126 (2008)
M. Schmidt et al., Conjugation of ciprofloxacin with poly(2-oxazoline)s and polyethylene glycol via end groups. Bioconjug. Chem. 26(9), 1950–1962 (2015)
S. He et al., Antibiotic-decorated titanium with enhanced antibacterial activity through adhesive polydopamine for dental/bone implant. J. R. Soc. Interface 11(95), 6 (2014)
M. Manefield et al., Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein. Microbiology 145(Pt 2), 283–291 (1999)
E.B. Hume et al., The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials 25(20), 5023–5030 (2004)
K.K.K. Ho et al., Immobilization of antibacterial dihydropyrrol-2-ones on functional polymer supports to prevent bacterial infections in vivo. Antimicrob. Agents Chemother. 56(2), 1138–1141 (2012)
S.M. Mathews et al., Prevention of bacterial colonization of contact lenses with covalently attached selenium and effects on the rabbit cornea. Cornea 25(7), 806–814 (2006)
P.L. Tran et al., An organoselenium compound inhibits Staphylococcus aureus biofilms on hemodialysis catheters in vivo. Antimicrob. Agents Chemother. 56(2), 972–978 (2012)
M. Bagheri, M. Beyermann, M. Dathe, Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum. Antimicrob. Agents Chemother. 53(3), 1132–1141 (2009)
R. Kuehl et al., Furanone at subinhibitory concentrations enhances staphylococcal biofilm formation by luxS repression. Antimicrob. Agents Chemother. 53(10), 4159–4166 (2009)
L. Ferreira, A. Zumbuehl, Non-leaching surfaces capable of killing microorganisms on contact. J. Mater. Chem. 19(42), 7796–7806 (2009)
S. Gon et al., How bacteria adhere to brushy peg surfaces: clinging to flaws and compressing the brush. Macromolecules 45(20), 8373–8381 (2012)
D.E. Fullenkamp et al., Mussel-inspired silver-releasing antibacterial hydrogels. Biomaterials 33(15), 3783–3791 (2012)
R. Hu et al., Silver–Zwitterion organic–inorganic nanocomposite with antimicrobial and antiadhesive capabilities. Langmuir 29(11), 3773–3779 (2013)
Z. Wang et al., Anti-bacterial superhydrophobic silver on diverse substrates based on the mussel-inspired polydopamine. Surf. Coat. Technol. 280, 378–383 (2015)
X. Ding et al., Antibacterial and antifouling catheter coatings using surface grafted PEG-b-cationic polycarbonate diblock copolymers. Biomaterials 33(28), 6593–6603 (2012)
K. Yu et al., Toward infection-resistant surfaces: achieving high antimicrobial peptide potency by modulating the functionality of polymer brush and peptide. ACS Appl. Mater. Interfaces 7(51), 28591–28605 (2015)
Z. Zhang, S. Chen, S. Jiang, Dual-functional biomimetic materials: nonfouling poly(carboxybetaine) with active functional groups for protein immobilization. Biomacromolecules 7(12), 3311–3315 (2006)
Z. Zhang et al., The hydrolysis of cationic polycarboxybetaine esters to zwitterionic polycarboxybetaines with controlled properties. Biomaterials 29(36), 4719–4725 (2008)
T. Dai et al., Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Expert Rev. Anti-Infect. Ther. 10(2), 185–195 (2012)
J. Bak, T. Begovic, A prototype catheter designed for ultraviolet C disinfection. J. Hosp. Infect. 84(2), 173–177 (2013)
J.C. Victor, D.T. Rowe, Optical fiber based antimicrobial ultraviolet radiation therapy system. US Patent Application 20160038621, 2016
M.A. Biel et al., Reduction of endotracheal tube biofilms using antimicrobial photodynamic therapy. Lasers Surg. Med. 43(7), 586–590 (2011)
T. Dahl, W.R. Midden, D.C. Neckers, Comparison of photodynamic action by Rose Bengal in gram-positive and gram-negative bacteria. Photochem. Photobiol. 48(5), 607–612 (1988)
N. Dror et al., Advances in microbial biofilm prevention on indwelling medical devices with emphasis on usage of acoustic energy. Sensors 9(4), 2538 (2009)
Z. Hazan et al., Effective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic waves. Antimicrob. Agents Chemother. 50(12), 4144–4152 (2006)
J.C. Carmen et al., Ultrasonic-enhanced gentamicin transport through colony biofilms of pseudomonas aeruginosa and Escherichia coli. J.Infect. Chemother. Off. J. Jpn. Soc. Chemother. 10(4), 193–199 (2004)
F. Harris, S.R. Dennison, D.A. Phoenix, The antimicrobial effects of ultrasound, in Novel Antimicrobial Agents and Strategies, (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2014), pp. 331–356
X. Wang et al., Sonodynamic action of hypocrellin B on biofilm-producing Staphylococcus epidermidis in planktonic condition. J. Acoust. Soc. Am. 138(4), 2548–2553 (2015)
V. Levering et al., Soft robotic concepts in catheter design: an on-demand fouling-release urinary catheter. Adv. Healthc. Mater. 3(10), 1588–1596 (2014)
V. Levering et al., Urinary catheter capable of repeated on-demand removal of infectious biofilms via active deformation. Biomaterials 77, 77–86 (2016)
Acknowledgments
The authors acknowledge the support from US Army Medical Research and Materiel Command (USAMRMC)’s Telemedicine & Advanced Technology Research Center (TATRC) under contract No. W81XWH-14-2-0015 and W81XWH-12-2-0084.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Zhang, Z., Wagner, V.E., Victor, J.C. (2017). Antimicrobial Modifications on Critical Care Implants. In: Zhang, Z., Wagner, V. (eds) Antimicrobial Coatings and Modifications on Medical Devices. Springer, Cham. https://doi.org/10.1007/978-3-319-57494-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-57494-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57492-9
Online ISBN: 978-3-319-57494-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)